Artwork

Innehåll tillhandahållet av BizNews. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av BizNews eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Obesity is not your fault nor just for the affluent - Prof Carel le Roux, World-leading SA Diabetes expert

20:04
 
Dela
 

Manage episode 418006082 series 2605825
Innehåll tillhandahållet av BizNews. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av BizNews eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
A recent Lancet study reveals that over one billion people worldwide are living with obesity, equating to one in eight individuals. In South Africa, where obesity is likened to a tsunami or epidemic, 43% of adults were overweight in 2022, with a significant portion of women, men, and children with weight-related issues. Professor Carel le Roux, a global authority on obesity and diabetes from South Africa, who is the Chair of Experimental Pathology at University College Dublin, told Biznews in an interview that there has been a shift in treating obesity as a disease rather than a personal failing. Regarding semaglutide drugs for the treatment of obesity, he said they are able to turn back the clock on Type 2 diabetes, but he cautions against viewing them as mere weight loss aids. “You’re going to regain all that weight, probably be worse off after you have stopped the treatment than before you started,” he said. For people with obesity and diabetes, it is a lifelong treatment. Referring to the cost of obesity drug treatment in South Africa, he said the cost of the drugs will fall over time as it happened with HIV treatment.
  continue reading

923 episoder

Artwork
iconDela
 
Manage episode 418006082 series 2605825
Innehåll tillhandahållet av BizNews. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av BizNews eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
A recent Lancet study reveals that over one billion people worldwide are living with obesity, equating to one in eight individuals. In South Africa, where obesity is likened to a tsunami or epidemic, 43% of adults were overweight in 2022, with a significant portion of women, men, and children with weight-related issues. Professor Carel le Roux, a global authority on obesity and diabetes from South Africa, who is the Chair of Experimental Pathology at University College Dublin, told Biznews in an interview that there has been a shift in treating obesity as a disease rather than a personal failing. Regarding semaglutide drugs for the treatment of obesity, he said they are able to turn back the clock on Type 2 diabetes, but he cautions against viewing them as mere weight loss aids. “You’re going to regain all that weight, probably be worse off after you have stopped the treatment than before you started,” he said. For people with obesity and diabetes, it is a lifelong treatment. Referring to the cost of obesity drug treatment in South Africa, he said the cost of the drugs will fall over time as it happened with HIV treatment.
  continue reading

923 episoder

Semua episod

×
 
Loading …

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

 

Snabbguide